Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - May 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for May 2019 (PDF).

This issue only contains one item relevant to primary care and that is a request to help to reverse the decline in reporting of suspected adverse drug reactions (ADRs). 2018 saw a fall in the number of reported suspected (ADRs) to the Yellow Card Scheme and this was consistent across several reporter groups including GP, hospital pharmacists, community pharmacists, hospital doctors and nurses. Readers are reminded of the ways Yellow Cards can be submitted and are reminded that duplicate reports can be detected. So, to avoid under-reporting, send a Yellow Card, even if you think someone else has done it.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'Drug Safety Update - May 2019' on Email Share 'Drug Safety Update - May 2019' on Delicious Share 'Drug Safety Update - May 2019' on Digg Share 'Drug Safety Update - May 2019' on Facebook Share 'Drug Safety Update - May 2019' on reddit Share 'Drug Safety Update - May 2019' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - May 2019”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer